Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Mar. 31, 2016
Current assets:
Cash	$ 192,322	$ 0
Prepaid expenses and other current assets	1,153	0
Income tax receivable	15	0
Total current assets	193,490	0
Property and equipment, net	471	0
Other assets	100	0
Total assets	194,061	0
Current liabilities:
Accrued expenses and accounts payable	3,890	223
Due to Roivant Sciences Ltd. and Roivant Sciences, Inc.	2,448	0
Total current liabilities	6,338	223
Warrant liability	1,655	0
Total liabilities	7,993	223
Commitments and contingencies (Note 9)
Shareholders’ equity (deficit):
Common shares, par value $0.000017727 per share, 564,111,242 shares authorized, 60,250,094 and 37,231,342 issued and outstanding at December 31, 2016 and March 31, 2016, respectively	1	1
Common shares subscribed	(1)	(1)
Additional paid-in capital	249,491	1,434
Accumulated deficit	(63,423)	(1,657)
Total shareholders’ equity (deficit)	186,068	(223)
Total liabilities and shareholders’ equity (deficit)	$ 194,061	$ 0

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.